Investing-News.Com
Information for Investors

ALPHARMA INC, (ALO) Stock Research - Investing-News.Com
 

 Home   Market News   Analysis   Commentary   Education   Tools   Weekly Report 

Internet Search   Stock Search
   

 

ALPHARMA INC, (ALO) Stock Research Free Stock Rating

 
Company Profile
 
Alpharma, Inc., a global specialty pharmaceutical company, engages in the development, manufacture, and marketing of specialty generic human pharmaceutical and animal pharmaceutical products. The company offers a range of generic human pharmaceutical products in tablet, capsule, liquid, and topical formulations and dosage forms. It operates in five segments: Active Pharmaceutical Ingredients (API), Branded Pharmaceuticals (BP), International Generics (IG), U.S. Generic Pharmaceuticals (USG), and Animal Health (AH). The API segment offers a range of antibiotic fermentation based active pharmaceutical ingredients that are used in the manufacture of finished dose pharmaceutical products. The BP segment manufactures, develops, and markets a prescription pain medicine in a capsule dosage form under the trademark Kadian. It also markets a third party's branded prescription product in a tablet dosage form Pexeva. The IG segment offers a range of prescription pharmaceuticals that comprises antibiotic, analgesic/antirheumatic, psychotropic cardiovascular, cough and cold, and corticosteroid therapeutic products; and over-the-counter products that include skin care, gastrointestinal care, and pain relief products for human use. The USG segment provides generic prescription, specialty branded, and over-the-counter pharmaceuticals for human use. The AH segment offers medicated feed additives for food producing animals, such as poultry, cattle, and swine. It sells products primarily to wholesalers, distributors, hospitals, long-term care providers, managed care providers, and mail order companies, as well as merchandising chains in the United States, the United Kingdom, Germany, the Netherlands, Scandinavia, western Europe, Indonesia, China, Asia-pacific, and certain Middle Eastern countries. The company was formed as A.L. Laboratories, Inc. in 1975 and changed its name to Alpharma, Inc. in 1994. Alpharma is headquartered in Fort Lee, New Jersey.

ALPHARMA INC Related

Alpharma INC. - Home Alpharma Inc. (NYSE:ALO), is a multinational pharmaceutical company with global leadership positions in products for humans and animals.
ALO: Profile for ALPHARMA INC - Yahoo! Finance See the company profile for ALPHARMA INC (ALO) including business summary, industry/sector information, number of employees, business summary, corporate governance, ...
ALO ALPHARMA INC ALO (ALPHARMA INC): Stock analyses and research by investors on UpDown.com ... 12.90. ALPHARMA INC (ALO) News & Analysis. View more ...
Sponsored Links:

Software Forces ALPHARMA INC Investors To Buy Low and Sell High The Position Cost Averaging Stock Investing Systems helps LONG-TERM investors in ALPHARMA INC buy low and sell high every time guaranteed. Click Here To Learn More

We Give Precision Entry & Exit Points on ALPHARMA INC. This software is specially designed to give precision entry and exit points on ALPHARMA INC, or any other stock you choose.
Click Here to learn how to take control of your trading.

How To Know When ALPHARMA INC Beats The Street. New Software Offers "One-Click" Stock Picks. The StockPickerRT will pick stocks for you every trading day based on earnings, volume & momentum. Maybe even ALPHARMA INC, if they make the cut.
Click Here & Learn To
Pick Winners In An Uncertain Market



Related Searches: www.valueline.com  free forex training  lg lw60 toronto  prospects of sbi magnum comma fund - growth 

Research Home


Article Search


Advanced Search

StreetInsider Alerts

Latest Headlines

Johnson & Johnson Firms Things Up (at Motley Fool)

Buyout or Sellout? (at Motley Fool)

UPDATE - Deals of the day -- mergers and acquisitions (at Reuters)

UPDATE - King mulls alternative financing for Alpharma deal (at Reuters)

Corrections & Amplifications (at The Wall Street Journal Online)

Stocks Offering 'Healthy' Returns (at Seeking Alpha)

Premarket roundup: Hewlett-Packard, King Pharma (AP)

Ahead of the Bell: King Pharmaceuticals (AP)

King Pharma's $1.6B offer wins over Alpharma (AP)

IBD's Top 10 - Monday (Investor's Business Daily)

  Place Our Content On Your Site!  rss Powered By The Investing System Network
© 2006 Investing-News.Com, All Rights Reserved.